Home Cart 0 Sign in  
X

[ CAS No. 49716-18-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 49716-18-9
Chemical Structure| 49716-18-9
Chemical Structure| 49716-18-9
Structure of 49716-18-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 49716-18-9 ]

Related Doc. of [ 49716-18-9 ]

Alternatived Products of [ 49716-18-9 ]

Product Details of [ 49716-18-9 ]

CAS No. :49716-18-9 MDL No. :MFCD09034966
Formula : C9H10ClN Boiling Point : -
Linear Structure Formula :- InChI Key :PASUADIMFGAUDB-UHFFFAOYSA-N
M.W : 167.64 Pubchem ID :11182839
Synonyms :

Calculated chemistry of [ 49716-18-9 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 0
Num. H-bond acceptors : 0.0
Num. H-bond donors : 1.0
Molar Refractivity : 51.35
TPSA : 12.03 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.25 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.12
Log Po/w (XLOGP3) : 2.92
Log Po/w (WLOGP) : 2.13
Log Po/w (MLOGP) : 2.64
Log Po/w (SILICOS-IT) : 3.08
Consensus Log Po/w : 2.58

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.12
Solubility : 0.126 mg/ml ; 0.000754 mol/l
Class : Soluble
Log S (Ali) : -2.83
Solubility : 0.246 mg/ml ; 0.00147 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.89
Solubility : 0.0217 mg/ml ; 0.00013 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.51

Safety of [ 49716-18-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 49716-18-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 49716-18-9 ]
  • Downstream synthetic route of [ 49716-18-9 ]

[ 49716-18-9 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 612-57-7 ]
  • [ 49716-18-9 ]
YieldReaction ConditionsOperation in experiment
95% With tetrahydroxydiboron; copper diacetate In acetonitrile at 40℃; for 12 h; 6-chloroquinoline (0.3 mmol, 49 mg)Tetrahydroxy diboron (0.9mmol, 81mg),Cu (OAc) 2 (0.015 mmol, 2.5 mg) was added to 1 mL of acetonitrile,40 ° C for 12 hours,The residue was purified by thin layer chromatography to give 47.6 mg of 6-chloro tetrahydroquinoline in 95percent yield, 98percent purity,
84% With tetrahydroxydiboron; copper diacetate In acetonitrile at 40℃; for 8 h; Schlenk technique General procedure: A 20 mL Schlenk tube was charged with quinoline (1a; 65 mg,0.5 mmol), Cu(OAc)2 (4.5 mg, 0.025 mmol), B2(OH)4 (135 mg,1.5 mmol), and MeCN (2.0 mL). The mixture was stirred at 40 °C for 8 h until the reaction was completed (TLC), then cooled to room temperature and concentrated under reduced pressure. Water (10 mL) was added and the mixture was extracted with EtOAc (3 x 10 mL). The organic phases were combined, dried over anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography with petroleum ether/ethyl acetate (8:1) as an eluent to give a brown liquid (2a: 65 mg, 98percent yield).
83% With palladium; hydrogen In acetonitrile at 30℃; for 16 h; To a solution of PdNPore (2.7 mg, 5 molpercent) in acetonitrile (5 mL) was added the substrate 6-chloroquinoline(81.8 mg, 0.5 mmol), hydrogen (5 bar), placed on a magnetic stirrer at 30 ° C for 16 h, column chromatography (silica gel, 200-300Methyl acetate) to give 6-chloro-1,2,3,4-tetrahydroquinoline 69.57 mg in 83percent yield,
79% With ethanol; Dimethylphenylsilane; Au-TiO2 In neat (no solvent) at 70℃; for 3 h; General procedure: To a dry vial containing 8-methoxyquinoline, 1 (0.048 g, 0.3 mmol), Me2PhSiH (185 μL, 1.2mmol) and ethanol (70 μL, 1.2 mmol), Au/TiO2 (60 mg, 1.0 molpercent) was added. The Au contentin catalyst was ~1 wtpercent. The mixture was heated to 70 oC and the progress of reaction wasmonitored by TLC and GC. After 15 min (100percent conversion), ethanol (1 mL) was added and theresulting slurry was filtered under reduced pressure through a short pad of silica gel with the aidof ethanol (2-3 mL) to withhold the supported catalyst. The filtrate was evaporated undervacuum and the residue was chromatographed (n-hexane/ethyl acetate, 10:1) to afford 8-methoxy-1,2,3,4-tetrahydroquinoline (1a) (41 mg, 84percent yield).
78%
Stage #1: With hydrogenchloride; hydrogen In ethanol; water at 20℃;
Stage #2: With sodium hydrogencarbonate In water
To a solution of 6-chloroquinoline (1.5 g, 9.17 mmol) in C2H5OH (50 ml) was added Pt02 (41.5 mg, 0.18 mmol) and concentrated HC1 (0.1 ml) under an atmosphere of hydrogen gas. The reaction was stirred overnight at room temperature, then concentrated in vacuo, diluted with water (100 ml), adjusted to pH 8 with aqueous sodium bicarbonate. The resulting solution was extracted with dichloromethane (3 x 80 ml) and the organic layers were combined, dried over anhydrous magnesium sulfate, concentrated in vacuo to afford 6-chloro-l,2,3,4- tetrahydroquinoline as a colorless oil (1.2 g, 78 ).LC/MS (ES, m/z) [M+H]+ 168.0'H-NMR (300 MHz, CDCI3) δ 6.90 - 6.98 (m, 2H), 6.39 - 6.42 (t, / = 1.2 Hz, 1H), 3.23 - 3.35 (m, 2H), 2.73 - 2.81 (m, 2H), 1.91 - 1.96 (m, 2H)
62% With hydrogen In methanol for 4 h; A flask filled with a mixture of 6-chloroquinoline (12.0 g, 73.3 mmol), PtO2 (2.16 g, 13 mol percent), and MeOH (500 mL, 6.15 M) was flushed with N2 and then equipped with a balloon filled with H2. The reaction was kept under H2 atmosphere and stirred for 4 h. The mixture was filtered through Celite and washed with CH2Cl2. Purification via silica gel chromatography using 50percent CH2Cl2 in hexanes gave 6-chloro-1,2,3,4-tetrahydroquinoline (7.7 g, 62percent). 1H NMR (400 MHz, DMSO-d6) δ 6.85-6.83 (m, 2H), 6.42-6.39 (m, 1H), 5.82 (s, 1H), 3.17-3.13 (m, 2H), 2.64 (t, J=6.3 Hz, 2H), 1.78-1.72 (m, 2H). LC/MS (10percent-99percent CH3CN (0.035percent TFA)/H2O (0.05percent TFA)), m/z: M+1 obs=168.2; tR=1.57 min.

Reference: [1] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 17, p. 7956 - 7967
[2] Angewandte Chemie - International Edition, 2016, vol. 55, # 50, p. 15656 - 15661[3] Angew. Chem., 2016, vol. 128, # 50, p. 15885 - 15890,6
[4] Organic Letters, 2013, vol. 15, # 7, p. 1484 - 1487
[5] Chemical Communications, 2013, vol. 49, # 63, p. 7052 - 7054
[6] Patent: CN106831565, 2017, A, . Location in patent: Paragraph 0103; 0104; 0105; 0106
[7] Tetrahedron Letters, 1987, vol. 28, # 1, p. 77 - 80
[8] Bulletin of the Chemical Society of Japan, 1989, vol. 62, # 9, p. 2968 - 2976
[9] Angewandte Chemie - International Edition, 2017, vol. 56, # 12, p. 3216 - 3220[10] Angew. Chem., 2017, vol. 129, # 12, p. 3264 - 3268,5
[11] Advanced Synthesis and Catalysis, 2015, vol. 357, # 16-17, p. 3529 - 3537
[12] Angewandte Chemie - International Edition, 2018, vol. 57, # 35, p. 11262 - 11266[13] Angew. Chem., 2018, vol. 130, # 35, p. 11432 - 11436,5
[14] Catalysis Science and Technology, 2017, vol. 7, # 10, p. 1981 - 1985
[15] Advanced Synthesis and Catalysis, 2015, vol. 357, # 4, p. 753 - 760
[16] Tetrahedron, 2018, vol. 74, # 17, p. 2121 - 2129
[17] Patent: CN106432072, 2017, A, . Location in patent: Paragraph 0056-0063
[18] Journal of the American Chemical Society, 2015, vol. 137, # 36, p. 11718 - 11724
[19] Arkivoc, 2015, vol. 2015, # 3, p. 38 - 51
[20] Patent: WO2012/94462, 2012, A2, . Location in patent: Page/Page column 72
[21] Journal of the American Chemical Society, 2018, vol. 140, # 1, p. 433 - 440
[22] Patent: US2008/27067, 2008, A1, . Location in patent: Page/Page column 264
[23] Catalysis Science and Technology, 2018, vol. 8, # 10, p. 2648 - 2653
[24] Synlett, 1998, # 9, p. 1029 - 1030
[25] Journal of the Chemical Society. Perkin Transactions 1, 2001, # 9, p. 955 - 977
[26] Chemische Berichte, 1922, vol. 55, p. 3780
[27] Chemische Berichte, 1913, vol. 46, p. 3182
[28] Helvetica Chimica Acta, 1985, vol. 68, p. 1952 - 1960
[29] Journal of the American Chemical Society, 2012, vol. 134, # 42, p. 17592 - 17598,7
[30] ACS Catalysis, 2016, vol. 6, # 9, p. 5816 - 5822
[31] Green Chemistry, 2017, vol. 19, # 3, p. 749 - 756
[32] Journal of the American Chemical Society, 2017, vol. 139, # 28, p. 9419 - 9422
[33] ACS Catalysis, 2018, vol. 8, # 1, p. 17 - 21
[34] Tetrahedron Letters, 2018, vol. 59, # 10, p. 949 - 953
[35] Organic Letters, 2018, vol. 20, # 4, p. 1171 - 1174
[36] Applied Catalysis A: General, 2018, vol. 560, p. 37 - 41
[37] Angewandte Chemie - International Edition, 2018, vol. 57, # 31, p. 9950 - 9954[38] Angew. Chem., 2018, vol. 130, p. 10098 - 10102,5
  • 2
  • [ 612-57-7 ]
  • [ 635-46-1 ]
  • [ 49716-18-9 ]
Reference: [1] Journal of the American Chemical Society, 2012, vol. 134, # 42, p. 17592 - 17598,7
[2] Molecular Catalysis, 2018, vol. 452, p. 145 - 153
  • 3
  • [ 612-57-7 ]
  • [ 635-46-1 ]
  • [ 49716-18-9 ]
  • [ 767-92-0 ]
Reference: [1] ACS Catalysis, 2016, vol. 6, # 9, p. 5816 - 5822
  • 4
  • [ 457622-18-3 ]
  • [ 49716-18-9 ]
Reference: [1] Organic Letters, 2002, vol. 4, # 16, p. 2691 - 2694
  • 5
  • [ 612-57-7 ]
  • [ 91-22-5 ]
  • [ 635-46-1 ]
  • [ 49716-18-9 ]
Reference: [1] Journal of the American Chemical Society, 2012, vol. 134, # 42, p. 17592 - 17598,7
[2] Journal of Materials Chemistry A, 2017, vol. 5, # 7, p. 3260 - 3266
  • 6
  • [ 612-57-7 ]
  • [ 67-63-0 ]
  • [ 49716-18-9 ]
Reference: [1] Tetrahedron Letters, 2004, vol. 45, # 16, p. 3215 - 3217
  • 7
  • [ 4169-19-1 ]
  • [ 49716-18-9 ]
Reference: [1] Journal of the American Chemical Society, 1952, vol. 74, p. 3176
[2] Chemical and Pharmaceutical Bulletin, 1980, vol. 28, # 12, p. 3639 - 3648
  • 8
  • [ 17049-49-9 ]
  • [ 49716-18-9 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2010, vol. 58, # 9, p. 1255 - 1258
  • 9
  • [ 635-46-1 ]
  • [ 49716-18-9 ]
  • [ 90562-36-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 17, p. 5119 - 5123
  • 10
  • [ 106-47-8 ]
  • [ 49716-18-9 ]
Reference: [1] Chemische Berichte, 1913, vol. 46, p. 3182
  • 11
  • [ 635-46-1 ]
  • [ 49716-18-9 ]
  • [ 90562-36-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 17, p. 5119 - 5123
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 49716-18-9 ]

Chlorides

Chemical Structure| 90562-33-7

[ 90562-33-7 ]

5-Chloro-1,2,3,4-tetrahydroquinoline hydrochloride

Similarity: 0.94

Chemical Structure| 303-49-1

[ 303-49-1 ]

3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine

Similarity: 0.89

Chemical Structure| 90562-34-8

[ 90562-34-8 ]

7-Chloro-1,2,3,4-tetrahydroquinoline hydrochloride

Similarity: 0.88

Chemical Structure| 90562-35-9

[ 90562-35-9 ]

7-Chloro-1,2,3,4-tetrahydroquinoline

Similarity: 0.88

Chemical Structure| 52598-02-4

[ 52598-02-4 ]

5-Chloro-2,3-diphenyl-1H-indole

Similarity: 0.85

Related Parent Nucleus of
[ 49716-18-9 ]

Tetrahydroquinolines

Chemical Structure| 90562-33-7

[ 90562-33-7 ]

5-Chloro-1,2,3,4-tetrahydroquinoline hydrochloride

Similarity: 0.94

Chemical Structure| 90562-34-8

[ 90562-34-8 ]

7-Chloro-1,2,3,4-tetrahydroquinoline hydrochloride

Similarity: 0.88

Chemical Structure| 90562-35-9

[ 90562-35-9 ]

7-Chloro-1,2,3,4-tetrahydroquinoline

Similarity: 0.88

Chemical Structure| 1783400-57-6

[ 1783400-57-6 ]

6,7-Dichloro-1,2,3,4-tetrahydroquinoline

Similarity: 0.84

Chemical Structure| 861368-85-6

[ 861368-85-6 ]

5-Methyl-1,2,3,4-tetrahydroquinoline hydrochloride

Similarity: 0.82